Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.
暂无分享，去创建一个
M. Morrison | A. Coxon | D. Whittington | A. Polverino | J. Harmange | Julie Flynn | Y. Teffera | J. Larrow | A. Long | Philip M. Roveto | Zhiyang Zhao | J. Bready | T. DeMelfi | J. Estrada | V. Patel | Matthew W. Martin | S. Harriman | D. La | M. Weiss | R. Graceffa | J. Belzile | Ling Wang | Nicholas Doerr | S. Flynn